Akebia Therapeutics, Inc.

AKBANASDAQHealthcare● Active

$0.94

+$0.00(+0.03%)

Market Cap$250982184

P/E Ratio—

52W High$4.079

52W Low$0.875

Avg Volume3.6M

Open$0.95

Beta0.25

Insider Trades Ownership Employees

Akebia Therapeutics, Inc.（AKBA）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · AKBA · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.04

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 4%仅显示有效交易 · 排除RSU归属96% Sell ↓

Akebia Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

AKBA 季度内部人买卖趋势

AKBA 内幕交易卖出 · AKBA 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

4.5M2.2M0

2023 Q2

2023 Q3

2024 Q1

2024 Q2

2025 Q1

2025 Q2

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · AKBA CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

AKBA 高管卖出股份 · AKBA 董事内幕交易 · SEC Form 4申报

显示最近 59 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Mar 4, 2026	Butler John P. CEO and President · Director	Purchase	69,270	$1.25	$87K	3,367,064	Form 4
Feb 2, 2026	Malabre Richard C SVP, Chief Accounting Officer	Sale	36,142	$1.39	$50K	312,772	Form 4
Feb 2, 2026	Malabre Richard C SVP, Chief Accounting Officer	Sale	13,382	$1.39	$19K	299,390	Form 4
Feb 2, 2026	Grund Nicholas Chief Commercial Officer	Sale	53,585	$1.39	$74K	592,994	Form 4
Feb 2, 2026	Grund Nicholas Chief Commercial Officer	Sale	31,244	$1.39	$43K	561,750	Form 4
Feb 2, 2026	Burke Steven Keith SVP, Chief Medical Officer	Sale	21,582	$1.39	$30K	994,508	Form 4
Feb 2, 2026	Burke Steven Keith SVP, Chief Medical Officer	Sale	25,375	$1.39	$35K	969,133	Form 4
Feb 2, 2026	Burke Steven Keith SVP, Chief Medical Officer	Sale	20,701	$1.39	$29K	948,432	Form 4
Feb 2, 2026	Rucci Carolyn M. SVP, Chief Legal Officer	Sale	16,846	$1.39	$23K	641,304	Form 4
Feb 2, 2026	Rucci Carolyn M. SVP, Chief Legal Officer	Sale	25,382	$1.39	$35K	615,922	Form 4
Feb 2, 2026	Rucci Carolyn M. SVP, Chief Legal Officer	Sale	27,544	$1.39	$38K	588,378	Form 4
Feb 2, 2026	Ostrowski Erik SVP, CFO, CBO & Treasurer	Sale	34,951	$1.39	$49K	672,635	Form 4
Feb 2, 2026	Butler John P. CEO and President · Director	Sale	46,660	$1.39	$65K	3,417,189	Form 4
Feb 2, 2026	Butler John P. CEO and President · Director	Award	175,250	$1.41	$247K	3,381,483	Form 4
Feb 2, 2026	Butler John P. CEO and President · Director	Sale	96,065	$1.39	$134K	3,321,124	Form 4
Feb 2, 2026	Butler John P. CEO and President · Director	Sale	83,689	$1.39	$116K	3,297,794	Form 4
Feb 2, 2026	Butler John P. CEO and President · Director	Sale	114,891	$1.39	$160K	3,206,233	Form 4
Jan 30, 2026	Grund Nicholas Chief Commercial Officer	Award	204,000	—	—	646,579	Form 4
Jan 30, 2026	Burke Steven Keith SVP, Chief Medical Officer	Award	204,000	—	—	1,016,090	Form 4
Jan 30, 2026	Rucci Carolyn M. SVP, Chief Legal Officer	Award	190,000	—	—	658,150	Form 4
Jan 30, 2026	Malabre Richard C SVP, Chief Accounting Officer	Award	79,000	—	—	348,914	Form 4
Jan 30, 2026	Ostrowski Erik SVP, CFO, CBO & Treasurer	Award	204,000	—	—	707,586	Form 4
Jan 30, 2026	Butler John P. CEO and President · Director	Award	743,000	—	—	3,463,849	Form 4
Jun 30, 2025	Ostrowski Erik SVP, CFO, CBO & Treasurer	Sale	41,314	$3.67	$152K	503,586	Form 4
Jun 10, 2025	ZUMWALT LEANNE M Director	Award	35,700	—	—	109,400	Form 4

Butler John P.

CEO and President · Director

Purchase

日期

Mar 4

股数

69,270

均价

$1.25

总金额

$87K

View Form 4 on SEC.gov

Malabre Richard C

SVP, Chief Accounting Officer

Sale

日期

Feb 2

股数

36,142

均价

$1.39

总金额

$50K

View Form 4 on SEC.gov

Malabre Richard C

SVP, Chief Accounting Officer

Sale

日期

Feb 2

股数

13,382

均价

$1.39

总金额

$19K

View Form 4 on SEC.gov

Grund Nicholas

Chief Commercial Officer

Sale

日期

Feb 2

股数

53,585

均价

$1.39

总金额

$74K

View Form 4 on SEC.gov

Grund Nicholas

Chief Commercial Officer

Sale

日期

Feb 2

股数

31,244

均价

$1.39

总金额

$43K

View Form 4 on SEC.gov

Burke Steven Keith

SVP, Chief Medical Officer

Sale

日期

Feb 2

股数

21,582

均价

$1.39

总金额

$30K

View Form 4 on SEC.gov

Burke Steven Keith

SVP, Chief Medical Officer

Sale

日期

Feb 2

股数

25,375

均价

$1.39

总金额

$35K

View Form 4 on SEC.gov

Burke Steven Keith

SVP, Chief Medical Officer

Sale

日期

Feb 2

股数

20,701

均价

$1.39

总金额

$29K

View Form 4 on SEC.gov

Rucci Carolyn M.

SVP, Chief Legal Officer

Sale

日期

Feb 2

股数

16,846

均价

$1.39

总金额

$23K

View Form 4 on SEC.gov

Rucci Carolyn M.

SVP, Chief Legal Officer

Sale

日期

Feb 2

股数

25,382

均价

$1.39

总金额

$35K

View Form 4 on SEC.gov

Rucci Carolyn M.

SVP, Chief Legal Officer

Sale

日期

Feb 2

股数

27,544

均价

$1.39

总金额

$38K

View Form 4 on SEC.gov

Ostrowski Erik

SVP, CFO, CBO & Treasurer

Sale

日期

Feb 2

股数

34,951

均价

$1.39

总金额

$49K

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Sale

日期

Feb 2

股数

46,660

均价

$1.39

总金额

$65K

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Award

日期

Feb 2

股数

175,250

均价

$1.41

总金额

$247K

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Sale

日期

Feb 2

股数

96,065

均价

$1.39

总金额

$134K

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Sale

日期

Feb 2

股数

83,689

均价

$1.39

总金额

$116K

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Sale

日期

Feb 2

股数

114,891

均价

$1.39

总金额

$160K

View Form 4 on SEC.gov

Grund Nicholas

Chief Commercial Officer

Award

日期

Jan 30

股数

204,000

均价

—

总金额

—

View Form 4 on SEC.gov

Burke Steven Keith

SVP, Chief Medical Officer

Award

日期

Jan 30

股数

204,000

均价

—

总金额

—

View Form 4 on SEC.gov

Rucci Carolyn M.

SVP, Chief Legal Officer

Award

日期

Jan 30

股数

190,000

均价

—

总金额

—

View Form 4 on SEC.gov

Malabre Richard C

SVP, Chief Accounting Officer

Award

日期

Jan 30

股数

79,000

均价

—

总金额

—

View Form 4 on SEC.gov

Ostrowski Erik

SVP, CFO, CBO & Treasurer

Award

日期

Jan 30

股数

204,000

均价

—

总金额

—

View Form 4 on SEC.gov

Butler John P.

CEO and President · Director

Award

日期

Jan 30

股数

743,000

均价

—

总金额

—

View Form 4 on SEC.gov

Ostrowski Erik

SVP, CFO, CBO & Treasurer

Sale

日期

Jun 30

股数

41,314

均价

$3.67

总金额

$152K

View Form 4 on SEC.gov

ZUMWALT LEANNE M

Director

Award

日期

Jun 10

股数

35,700

均价

—

总金额

—

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 AKBA 内幕交易

AKBA 内幕交易

Akebia Therapeutics, Inc.（AKBA）内幕交易数据来源于公司内部人（包括Butler John P. (CEO and President · Director), Burke Steven Keith (SVP, Chief Medical Officer), Rucci Carolyn M. (SVP, Chief Legal Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AKBA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Akebia Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

AKBA 内幕交易 · 5个问题

Akebia Therapeutics, Inc.（AKBA）的内部人包括高管和董事，如Butler John P. (CEO and President · Director), Burke Steven Keith (SVP, Chief Medical Officer), Rucci Carolyn M. (SVP, Chief Legal Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

AKBA 董事内幕交易AKBA 内部人名单Akebia Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026